Team Clinic group care for teens with type 2 diabetes
Implementation of Team Clinic for Type 2 Diabetes (TCT2): A Randomized Standard Care-controlled Two-site 80-subject Clinical Trial of Shared Medical Appointment Model for Adolescents With Type 2 Diabetes
NA · Children's Hospital Los Angeles · NCT06923046
This project tests whether shared medical appointments (Team Clinic) help teens aged 12–18 with type 2 diabetes feel better supported and improve psychosocial outcomes compared with usual care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Sponsor | Children's Hospital Los Angeles (other) |
| Locations | 2 sites (Los Angeles, California and 1 other locations) |
| Trial ID | NCT06923046 on ClinicalTrials.gov |
What this trial studies
Adolescents with type 2 diabetes and their caregivers are randomized to quarterly shared medical appointments plus group activities or to standard individual care at participating clinics. Participants complete surveys on psychosocial outcomes and attend scheduled clinic visits over the study period. The intervention is delivered in person at Children’s Hospital Los Angeles or UCSF and involves caregivers who speak English or Spanish. Researchers will compare survey results and engagement between the Team Clinic group and standard-of-care group.
Who should consider this trial
Good fit: English-speaking youth aged 12–18 who receive care for type 2 diabetes at CHLA or UCSF, are prescribed diabetes medication, and whose caregiver (English or Spanish speaking) can attend visits are ideal candidates.
Not a fit: Patients who are non-verbal, pregnant, unable or unwilling to participate in group discussions, or unable to attend in-person clinic visits are unlikely to benefit from this group-based model.
Why it matters
Potential benefit: If successful, Team Clinic could improve psychosocial well-being, peer support, and engagement in care for adolescents with type 2 diabetes.
How similar studies have performed: Shared medical appointments have shown positive effects for adults with diabetes and for some pediatric chronic conditions, but applying this model specifically to adolescents with type 2 diabetes is relatively novel and not yet widely proven.
Eligibility criteria
Show full inclusion / exclusion criteria
Patient/AYA Participants Inclusion Criteria: * Receives care for type 2 diabetes at either CHLA or UCSF * English speaking youth * Youth prescribed medication for type 2 diabetes * English or Spanish speaking caregivers * Age 12 to 18 years old at the time of enrollment * Willingness to attend clinic visits and participate in group session (if randomized to Team Clinic), complete surveys Exclusion Criteria: * Participants who are non-verbal or unable to participate in group activities and discussions * Pregnancy * Inability or unwillingness of individual or legal guardian/representative to give written informed assent/consent Caregiver/Parents Participants Inclusion Criteria: * Has a child between the ages of 12 and up to 18 at the time of enrollment who receives care for T2D in the endocrinology clinic at CHLA. The child must provide consent/assent to participate as a youth participant. * Speaks English of Spanish. Over 95% of our T2D population speaks one of those two languages. Our facilitator will be bilingual in English and Spanish. It is not feasible for the facilitator to also speak another language. Having a language interpreter for discussion groups will affect the dynamics and flow of the group session * Willingness to participate in group session (if their child is randomized to Team Clinic) and complete surveys. Exclusion Criteria: -Inability or unwillingness of individual to give written informed consent
Where this trial is running
Los Angeles, California and 1 other locations
- Children's Hospital Los Angeles — Los Angeles, California, United States (RECRUITING)
- University of California, San Francisco — San Francisco, California, United States (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: Lily Chao, MD — Children's Hospital Los Angeles
- Study coordinator: Fatima Aguilar
- Email: faguilar@chla.usc.edu
- Phone: 323-361-4606
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type 2 Diabetes